A Clinical Trial to investigate biomarker effects of pre-surgical treatment with DDR agents in patients with Head and Neck Squamous Cell Carcinoma (HNSCC) who are planned to undergo surgery that is likely to be followed by radiotherapy and/or chemotherapy

Research Summary

Research Overview
Sponsor AstraZeneca
Project Status Open
Proposed End Date 30/09/2019
Study Run through CRF? Yes
Target number of patients agreed to recruit 2
Recruitment so far 0